SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Go back to SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
(NASDAQ: CMND) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High
Open $1.03    52 Week Low
Day High $1.03    P/E N/A 
Day Low $1.03    EPS
Volume 21,190       

(NASDAQ: SPRC) Delayed: 5.10 --0 (-0%)
Previous Close $5.10    52 Week High
Open $5.10    52 Week Low
Day High $5.10    P/E N/A 
Day Low $5.10    EPS
Volume      

(NASDAQ: SPRC) Delayed: 5.10 --0 (-0%)
Previous Close $5.10    52 Week High
Open $5.10    52 Week Low
Day High $5.10    P/E N/A 
Day Low $5.10    EPS
Volume